日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Potent antitumor activity through dual targeting of PD-L1 and TGF-β pathways in the glioma tumor microenvironment

通过双重靶向胶质瘤肿瘤微环境中的PD-L1和TGF-β通路发挥强效抗肿瘤活性

Silginer, Manuela; Weller, Michael; Becher, Burkhard; Mastall, Maximilian; Weiss, Tobias; Nuñez, Nicolas Gonzalo; Kienzler, Jenny C; Roth, Patrick

Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics

基于整合多组学的髓母细胞瘤中天然呈递的T细胞抗原图谱

Julia Velz # ,Lena K Freudenmann # ,Gioele Medici # ,Marissa Dubbelaar ,Malte Mohme ,David R Ghasemi ,Jonas Scheid ,Daniel J Kowalewski ,Angelica B Patterson ,Anna M Zeitlberger ,Katrin Lamszus ,Manfred Westphal ,Matthias Eyrich ,Martina Messing-Jünger ,Andreas Röhrig ,Harald Reinhard ,Kévin Beccaria ,Rogeiro B Craveiro ,Beat M Frey ,Martin Sill ,Sven Nahnsen ,Marie Gauder ,Konstantina Kapolou ,Manuela Silginer ,Tobias Weiss ,Hans-Georg Wirsching ,Patrick Roth ,Michael Grotzer ,Niklaus Krayenbühl ,Oliver Bozinov ,Luca Regli ,Hans-Georg Rammensee ,Elisabeth J Rushing ,Felix Sahm ,Juliane S Walz ,Michael Weller ,Marian C Neidert

Simultaneous TGF-β and GITR pathway modulation promotes anti-tumor immunity in glioma

同时调节TGF-β和GITR通路可促进胶质瘤的抗肿瘤免疫。

Lorizio, Daniela; Silginer, Manuela; Friesen, Julia; Epstein, Alan L; Weller, Michael; Roth, Patrick

Targeting the IDH1 R132H mutation in gliomas by CRISPR/Cas precision base editing

通过 CRISPR/Cas 精确碱基编辑靶向胶质瘤中的 IDH1 R132H 突变

Remi Weber, Flavio Vasella, Artsiom Klimko, Manuela Silginer, Martine Lamfers, Marian Christoph Neidert, Luca Regli, Gerald Schwank, Michael Weller

Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma

基于嵌合抗原受体 T 细胞的 CD317 靶向治疗作为针对胶质母细胞瘤的新型免疫治疗策略

Lena Hänsch, Matthias Peipp, Maximilian Mastall, Danielle Villars, Renier Myburgh, Manuela Silginer, Tobias Weiss, Dorothee Gramatzki, Flavio Vasella, Markus G Manz, Michael Weller, Patrick Roth

A T-cell antigen atlas for meningioma: novel options for immunotherapy

脑膜瘤的 T 细胞抗原图谱:免疫治疗的新选择

Gioele Medici #, Lena K Freudenmann #, Julia Velz #, Sophie Shih-Yüng Wang, Konstantina Kapolou, Nagarajan Paramasivam, Lena Mühlenbruch, Daniel J Kowalewski, Flavio Vasella, Tatjana Bilich, Beat M Frey, Marissa L Dubbelaar, Angelica Brooke Patterson, Anna Maria Zeitlberger, Manuela Silginer, Patric

Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition

免疫学和肿瘤内在机制介导放射治疗和 MET 抑制对实验性胶质母细胞瘤的协同生长抑制

Manuela Silginer, Eleanna Papa, Emese Szabó, Flavio Vasella, Martin Pruschy, Christopher Stroh, Patrick Roth, Tobias Weiss, Michael Weller

Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models

I型干扰素信号在实验性胶质瘤模型中肿瘤细胞与宿主细胞中的不同作用

Evelina Blomberg ,Manuela Silginer ,Patrick Roth ,Michael Weller

JS08.5.A VEGFR2-SPECIFIC CAR T CELLS WITH ANTI-GLIOMA AND ANTI-ANGIOGENIC ACTIVITY AGAINST GLIOBLASTOMA

JS08.5.A 具有抗胶质瘤和抗胶质母细胞瘤血管生成活性的 VEGFR2 特异性 CAR-T 细胞

Kim, Jung; Yu, Jindan; Mastall, M; Villars, D; Silginer, M; Rössig, C; Weiss, T; Weller, M; Roth, P

CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner

CD95基因缺失可能以不依赖于CD95配体的方式降低人胶质母细胞瘤细胞的克隆形成能力和侵袭性。

Clara Quijano-Rubio ,Manuela Silginer ,Michael Weller